Abstract
PURPOSE OF REVIEW: The purpose of this review is to examine the appropriateness of coronary artery bypass grafting (CABG) for the patient with ischemic cardiomyopathy and congestive heart failure. RECENT FINDINGS: CABG is the gold standard therapy for patients with advanced multivessel and left main coronary artery disease. A critical analysis of the Surgical Treatment of Ischemic Heart Failure (STICH) trial confirms the benefit of CABG for patients with ischemic cardiomyopathy. SUMMARY: CABG can be safely applied to patients with heart failure and provides benefit for appropriately selected patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 629-633 |
| Number of pages | 5 |
| Journal | Current opinion in cardiology |
| Volume | 27 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 2012 |
Keywords
- Surgical Treatment of Ischemic Heart Failure (STICH) trial
- heart failure
- ischemic cardiomyopathy
- myocardial viability
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine